Search - tctmd.com

Displaying 701 - 720 of 1300

Sort: Relevancy | Date

News Daily News

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

L.A. McKeown

March 27, 2014

News Daily News

Meta Análisis: La Alta Reactividad Plaquetaria se asocia a un Mayor Riesgo de ACV tras PCI

L.A. McKeown

March 27, 2014

Presentation

Risk of Stroke in Patients with High On-Clopidogrel Platelet Reactivity to Adenosine Diphosphate after PCI

Presenter: Nevio Taglieri

March 25, 2014

News Daily News

Statins More Beneficial Before PCI Than After in ACS Patients

March 13, 2014

News Daily News

Meta Análisis de los Beneficios Temporales del Tratamiento con Estatinas en Pacientes víctimas de SCA sometidos a PCI

March 13, 2014

Presentation

Meta-analysis of Time-Related Benefits of Statin Therapy in Patients with ACS Undergoing PCI

Presenter: Eliano Pio Navarese

March 10, 2014

News Daily News

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Caitlin E. Cox

February 26, 2014

Presentation

INFUSE-AMI: Outcomes in Patients with STEMI Treated with Clopidogrel vs Prasugrel

Presenter: Sorin J. Brener

February 26, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

Presentation

Impact of Major Bleeding on Long-term Mortality in Anemic Patients Undergoing PCI Using Bivalirudin

Presenter: Ziad A. Ali

February 25, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

Presentation

Lack of Association Between DAPT Use and Stent Thrombosis Between 1 and 12 Months Following Resolute ZES Implantation

Presenter: 115704|Sigmund Silber

February 17, 2014

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

News Daily News

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

Yael L. Maxwell

February 13, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Daily News

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

L.A. McKeown

February 06, 2014

News Daily News

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

L.A. McKeown

February 06, 2014

Presentation

Early Post-discharge Bleeding and Antiplatelet Discontinuation in AMI Patients Treated with PCI

Presenter: 222318|Tracy Wang

February 03, 2014

News Daily News

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

Caitlin E. Cox

January 29, 2014

Advertisement

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

Meta Análisis: La Alta Reactividad Plaquetaria se asocia a un Mayor Riesgo de ACV tras PCI

Risk of Stroke in Patients with High On-Clopidogrel Platelet Reactivity to Adenosine Diphosphate after PCI

Statins More Beneficial Before PCI Than After in ACS Patients

Meta Análisis de los Beneficios Temporales del Tratamiento con Estatinas en Pacientes víctimas de SCA sometidos a PCI

Meta-analysis of Time-Related Benefits of Statin Therapy in Patients with ACS Undergoing PCI

与华法林或阿司匹林相比，阿哌沙班更具成本效益

INFUSE-AMI: Outcomes in Patients with STEMI Treated with Clopidogrel vs Prasugrel

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Impact of Major Bleeding on Long-term Mortality in Anemic Patients Undergoing PCI Using Bivalirudin

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Lack of Association Between DAPT Use and Stent Thrombosis Between 1 and 12 Months Following Resolute ZES Implantation

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

Early Post-discharge Bleeding and Antiplatelet Discontinuation in AMI Patients Treated with PCI

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content